Limitations and enhancement opportunities for variceal rebleeding prediction model in patients with cirrhosis  

作　　者：Guang-Bin Chen Fei Wu Rong-Mei Tang Long-Jiang Chen 

机构地区：[1]Department of Hepatobiliary Surgery,The Second People's Hospital of Wuhu,Wuhu Hospital Affiliated to East China Normal University,Wuhu 241000,Anhui Province,China [2]Graduate School,Wannan Medical College,Wuhu 241000,Anhui Province,China [3]Department of Anesthesiology,Fudan University Shanghai Cancer Center Xiamen Hospital,Xiamen 361000,Fujian Province,China [4]Department of Hepatobiliary Surgery,Affiliated Yijishan Hospital of Wannan Medical College,Wuhu 241000,Anhui Province,China

出　　处：《World Journal of Gastroenterology》2025年第8期161-163,共3页世界胃肠病学杂志(英文)

摘　　要：A multicenter study recently published introduced a novel prognostic model for predicting esophagogastric variceal rebleeding after endoscopic treatment in patients with cirrhosis.The model incorporated six readily available clinical variables—albumin level,aspartate aminotransferase level,white blood cell count,ascites,portal vein thrombosis,and bleeding signs—and demonstrated promising predictive performance.However,limitations,including the retrospective design and exclusion of patients with hepatocellular carcinoma,may affect the generaliz-ability of the model.Additionally,further improvement is needed in the model’s discrimination between intermediate-and high-risk groups in external.Prospec-tive validation and inclusion of additional variables are recommended to enhan-ce predictive accuracy across diverse clinical scenarios.

关 键 词：Prognostic model Liver cirrhosis Variceal rebleeding Risk stratification Endoscopic treatment Portal hypertension Clinical prediction 

分 类 号：R575.2[医药卫生—消化系统]